P01-011 – Colchicine compliance and amyloidosis

Por Ozdogan, H, Ugurlu, S, Hatemi, G
Publicado em 2013

How safe it is to treat pregnant FMF patients with Anakinra?

Por Ozdogan, H, Ugurlu, S, Ergezen, B
Publicado no Pediatr Rheumatol Online J (2015)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience

Por Ugurlu, S, Ergezen, B, Ozdogan, H
Publicado no Pediatr Rheumatol Online J (2015)

Acute phase response in familial Mediterranean fever

Por Korkmaz, C, Ozdogan, H, Kasapcopur, O, Yazici, H
Publicado em 2002

PW01-012 – Canakinumab in patients with FMF

Por Ugurlu, S, Seyahi, E, Hatemi, G, Hacioglu, A, Ozdogan, H
Publicado em 2013

P01-015 – Effect of Cochicine on cholesterol in FMF and BS

Por Ugurlu, S, Seyahi, E, Hanci, I, Pehlevan, SM, Ozdogan, H, Yazici, H
Publicado em 2013

A case with febrile attacks and vasculopathy associated with ADA2 and MEFV gene mutations

Por Ozdogan, H, Ugurlu, S, Hacioglu, A, Turanli, E Tahir, Aydin, A Kirectepe
Publicado no Pediatr Rheumatol Online J (2015)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF

Por Gul, A, Özdogan, H, Kasapcopur, O, Erer, B, Ugurlu, S, Sevgi, S, Turgay, S
Publicado no Pediatr Rheumatol Online J (2015)

Observer variation in grading sacroiliac radiographs might be a cause of 'sacroiliitis' reported in certain disease states.

Por Yazici, H, Turunç, M, Ozdoğan, H, Yurdakul, S, Akinci, A, Barnes, C G
Publicado em 1987

PW01-015 – Canakinumab in adults with colchicin resistant FMF

Por Gül, A, Özdoğan, H, Kasapçopur, Ö, Erer, B, Uğurlu, S, Davis, N, Sevgi, S
Publicado em 2013

Canakinumab therapy in patients with Familial Mediterranean Fever

Por Ugurlu, S, Seyahi, E, Hatemi, G, Hacioglu, A, Ozcan, H, Akkoc, FN, Ozdogan, H
Publicado no Pediatr Rheumatol Online J (2015)

Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey

Por Ozdogan, H, Ugurlu, S, Hatemi, G, Ozgun, E, Can, G, Ozgon, G, Ergezen, B
Publicado no Pediatr Rheumatol Online J (2015)

OR14-002 - ANTI IL-1 therapies and pregnancy outcome

Por Lachmann, HJ, Ozdogan, H, Simon, A, Stewart, N, Rowczenio, DM, Ugurlu, S, Lane, T, Hawkins, PN
Publicado em 2013

PW02-011 - Favorable response to anakinra in aisle patients

Por Ozdogan, H, Gattorno, M, Ugurlu, S, Di Rocco, M, Hatemi, G, Ustek, D, Gul, A
Publicado em 2013

The frequency of MEFV gene variations in Adult-onset Still's disease and Gout

Por Ugurlu, S, Emekli, AS, Turanli, E Tahir, Benyakar, SG, Erdem, G Çelikyapı, Ozdogan, H, Seyahi, E
Publicado no Pediatr Rheumatol Online J (2015)

Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)

Por Gul, A, Ozdogan, H, Ugurlu, S, Kasapcopur, O, Buyukbabani, N, Emekli, U, Emrence, Z, Ustek, D
Publicado no Pediatr Rheumatol Online J (2015)

Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.

Por Yazici, H, Tüzün, Y, Pazarli, H, Yurdakul, S, Ozyazgan, Y, Ozdoğan, H, Serdaroğlu, S, Ersanli, M, Ulkü, B Y, Müftüoğlu, A U
Publicado em 1984

PReS-FINAL-2328: Developing and validating the new severity score for FMF

Por Demirkaya, E, Acikel, C, Gul, A, Gattorno, M, Ben-Chetrit, E, Ozdogan, H, Hashkes, P, Polat, A, Livneh, A, Ozen, S
Publicado em 2013

PW01-028 – Developing a new severity score for FMF

Por Demirkaya, E, Acikel, C, Gul, A, Gattorno, M, Ben-Chetrit, E, Ozdogan, H, Hashkes, P, Polat, A, Karadag, O, Livneh, A, Ozen, S
Publicado em 2013

International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors

Por Youngstein, T, Hoffmann, P, Lane, T, Williams, R, Rowczenio, D, Ozdogan, H, Urgurlu, S, Ryan, J, Harty, L, Riminton, S, Headley, A, Roesler, J, Blank, N, Michler, C, Simon, A, Hawkins, P, Lachmann, H
Publicado no Pediatr Rheumatol Online J (2015)